Benefit of adjuvant immunotherapy in renal cell carcinoma: A myth or a reality?
<h4>Background</h4>The benefit of adjuvant immunotherapy after nephrectomy in renal cell carcinoma (RCC) is controversial. The present study aimed to examine the possible benefit of adjuvant immunotherapy in various clinical settings.<h4>Methods</h4>We retrospectively reviewed 436 patients with pT1-...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Public Library of Science (PLoS)
2017-01-01
|
| Serija: | PLoS ONE |
| Online pristup: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0172341&type=printable |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|